Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Terlipressin Versus Placebo for Septic Shock Refractory to High Doses Catecholamine Vasopressors: A Randomized-controlled Trial

NCT04339868 is registered in ClinicalTrials.gov with Mahidol University as lead sponsor.

NCT NCT04339868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04339868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Terlipressin Versus Placebo for Septic Shock Refractory to High Doses Catecholamine Vasopressors: A Randomized-controlled Trial
Lead sponsor
Mahidol University
Phase
Phase 2
Overall status
Unknown status
Start date
April 3, 2020
Completion date
July 31, 2025
Enrollment
130 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

norepinephrine adverse reaction, refractory shock, septic shock